{"id":"https://openalex.org/W4307431333","doi":"https://doi.org/10.1089/aid.2022.0085","title":"EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water","display_name":"EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water","publication_year":2022,"publication_date":"2022-10-27","ids":{"openalex":"https://openalex.org/W4307431333","doi":"https://doi.org/10.1089/aid.2022.0085","pmid":"https://pubmed.ncbi.nlm.nih.gov/36301928","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9910106"},"language":"en","primary_location":{"id":"doi:10.1089/aid.2022.0085","doi":"https://doi.org/10.1089/aid.2022.0085","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2022.0085","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9910106/pdf/aid.2022.0085.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046729854","display_name":"Adriana S. Andrade","orcid":"https://orcid.org/0000-0002-6984-5920","observed_orcids":["https://orcid.org/0000-0002-6984-5920"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriana Andrade","raw_affiliation_strings":["DAIDS, NIAID, NIH, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DAIDS, NIAID, NIH, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045625987","display_name":"Edward J. Fuchs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward J. Fuchs","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082007029","display_name":"Mark A. Marzinke","orcid":"https://orcid.org/0000-0003-1670-8786","observed_orcids":["https://orcid.org/0000-0003-1670-8786"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Marzinke","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047443931","display_name":"Sandra Abdul Massih","orcid":"https://orcid.org/0000-0003-3544-1319","observed_orcids":["https://orcid.org/0000-0003-3544-1319"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Abdul Massih","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0003-3544-1319","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109886894","display_name":"Jennifer Breakey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Breakey","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016516842","display_name":"Sasha Beselman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sasha Beselman","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012099672","display_name":"Ian R. McNicholl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian McNicholl","raw_affiliation_strings":["Gilead Sciences, Inc., Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053567182","display_name":"Craig W. Hendrix","orcid":"https://orcid.org/0000-0002-5696-8665","observed_orcids":["https://orcid.org/0000-0002-5696-8665"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Craig W. Hendrix","raw_affiliation_strings":["Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5053567182"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16569085,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"1","first_page":"38","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0430000014603138,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9139999747276306},{"id":"https://openalex.org/keywords/tablet-dissolution","display_name":"tablet dissolution","score":0.5630000233650208},{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cobicistat","display_name":"cobicistat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9599999785423279},{"id":"https://openalex.org/keywords/fixed-dose-combination-antiretroviral-therapy","display_name":"fixed-dose combination antiretroviral therapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.44600000977516174},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6899999976158142},{"id":"https://openalex.org/keywords/dysphagia","display_name":"dysphagia","score":0.6039999723434448},{"id":"https://openalex.org/keywords/plasma-pharmacokinetics","display_name":"plasma pharmacokinetics","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.8755977749824524},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8683480024337769},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.8234574794769287},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.8161220550537109},{"id":"https://openalex.org/C2780524789","wikidata":"https://www.wikidata.org/wiki/Q5138908","display_name":"Cobicistat","level":5,"score":0.7661522030830383},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.752608060836792},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5344710946083069},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5248061418533325},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4001966416835785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3727928102016449},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.3377543091773987},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2054208517074585},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.07330179214477539},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069547","descriptor_name":"Cobicistat","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1089/aid.2022.0085","doi":"https://doi.org/10.1089/aid.2022.0085","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2022.0085","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9910106","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9910106","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9910106/pdf/aid.2022.0085.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Res Hum Retroviruses","raw_type":"Text"},{"id":"pmid:36301928","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36301928","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and human retroviruses","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:9910106","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9910106","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9910106/pdf/aid.2022.0085.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Res Hum Retroviruses","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2483435703","display_name":null,"funder_award_id":"P30 AI 094189","funder_id":"https://openalex.org/F4320310145","funder_display_name":"Johns Hopkins University"},{"id":"https://openalex.org/G653582874","display_name":null,"funder_award_id":"P30AI094189","funder_id":"https://openalex.org/F4320334051","funder_display_name":"Center for AIDS Research, Johns Hopkins University"},{"id":"https://openalex.org/G7178514535","display_name":null,"funder_award_id":"P30AI094189","funder_id":"https://openalex.org/F4320332582","funder_display_name":"Center for AIDS Research, University of Washington"}],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320332582","display_name":"Center for AIDS Research, University of Washington","ror":"https://ror.org/00cvxb145"},{"id":"https://openalex.org/F4320334051","display_name":"Center for AIDS Research, Johns Hopkins University","ror":"https://ror.org/05n52x113"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4307431333.pdf","grobid_xml":"https://content.openalex.org/works/W4307431333.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1839037102","https://openalex.org/W1895220657","https://openalex.org/W1971176683","https://openalex.org/W2008357700","https://openalex.org/W2027115948","https://openalex.org/W2034159424","https://openalex.org/W2061741734","https://openalex.org/W2109242366","https://openalex.org/W2109360985","https://openalex.org/W2121737909","https://openalex.org/W2134537454","https://openalex.org/W2155441883","https://openalex.org/W2345546077","https://openalex.org/W2422955030","https://openalex.org/W2559683026","https://openalex.org/W2582476650","https://openalex.org/W2746562707","https://openalex.org/W2768030451","https://openalex.org/W2784305126","https://openalex.org/W2789526849","https://openalex.org/W2803193798","https://openalex.org/W2907582650","https://openalex.org/W2960064425","https://openalex.org/W2981218308","https://openalex.org/W3014830560","https://openalex.org/W3159035779","https://openalex.org/W4210331312"],"related_works":["https://openalex.org/W4307968273","https://openalex.org/W1996021566","https://openalex.org/W1546135304","https://openalex.org/W2093332167","https://openalex.org/W2900357731","https://openalex.org/W2902271435","https://openalex.org/W2352417586","https://openalex.org/W2950942724","https://openalex.org/W2332917663","https://openalex.org/W2033707081"],"abstract_inverted_index":{"Medication":[0],"adherence":[1],"can":[2],"be":[3,295,303],"challenging":[4],"for":[5,109,213,305],"persons":[6],"with":[7,21,101,121,158,205,233,307],"difficulty":[8],"swallowing":[9,309],"tablets.":[10],"We":[11],"investigated":[12],"the":[13,28,63,134,137,162,167,192,206,230,234],"bioequivalence":[14,156],"of":[15,23,27,62],"a":[16,24,58,74,102],"dissolved":[17,67,79,207,231,265,288],"tablet":[18,26,65,68,80,88],"when":[19,228,260,286],"compared":[20,232],"that":[22],"whole":[25,64,86,235],"fixed-dose":[29],"combination":[30],"elvitegravir":[31],"(EVG)/cobicistat":[32],"(COBI)/emtricitabine":[33],"(FTC)/tenofovir":[34],"(TFV)":[35],"alafenamide":[36],"fumarate":[37],"(TAF).":[38],"A":[39],"within-subject":[40],"fixed-order":[41],"two-period":[42],"open-label":[43],"study":[44],"was":[45,81,155,195,210,313],"conducted":[46],"in":[47,267,275,279,300],"12":[48,172],"HIV-negative":[49],"research":[50],"participants":[51],"after":[52,262],"obtaining":[53],"informed":[54],"consent.":[55],"Participants":[56],"took":[57],"single":[59],"dose":[60],"each":[61],"and":[66,94,117,133,178,191,218,225,240,251,256,269,277,281],"under":[69,136],"direct":[70],"observation,":[71],"separated":[72],"by":[73,83,223],"14-day":[75],"washout":[76],"period.":[77],"The":[78,152,311],"prepared":[82],"adding":[84],"one":[85],"EVG/COBI/FTC/TAF":[87,264,299],"to":[89,141,294],"120":[90],"mL":[91],"tap":[92],"water":[93,268,301],"stirring.":[95],"Both":[96],"dosage":[97],"types":[98],"were":[99,107,119,146,175,180,184,188,200,221,243,254,284,292],"taken":[100,261],"standardized":[103],"meal.":[104],"Plasma":[105,113],"samples":[106],"obtained":[108],"72":[110],"h":[111],"postdose.":[112],"EVG,":[114],"FTC,":[115],"TAF,":[116],"TFV":[118,248,282],"analyzed":[120],"liquid":[122],"chromatographic-tandem":[123],"mass":[124],"spectrometric":[125],"methods.":[126],"Peak":[127],"plasma":[128],"concentration":[129],"(C":[130],"max":[131,217,242,250],")":[132,145],"area":[135],"concentration-time":[138],"curve":[139],"extrapolated":[140],"infinity":[142],"(AUC":[143],"0\u2212\u221e":[144],"estimated":[147],"using":[148,161],"WinNonlin":[149],"software":[150],"(v.8.3).":[151],"primary":[153],"outcome":[154],"consistent":[157],"FDA":[159],"guidance":[160],"90%":[163],"confidence":[164],"interval":[165],"or":[166],"geometric":[168],"mean":[169,193],"ratio.":[170],"Of":[171],"participants,":[173],"7":[174],"black":[176],"(58%)":[177],"5":[179],"white":[181],"(42%),":[182],"4":[183],"women":[185],"(33%),":[186],"8":[187],"men":[189],"(67%),":[190],"age":[194],"43.6":[196],"years":[197],"(23\u201354).":[198],"There":[199],"no":[201,271],"complaints":[202],"about":[203],"taste":[204],"tablet.":[208,236],"Bioequivalence":[209],"established":[211],"only":[212],"FTC.":[214],"EVG":[215,276],"C":[216,241,249],"AUC":[219,238,252],"0\u2013\u221e":[220,239,253],"higher":[222],"18%":[224],"12%,":[226],"respectively,":[227,259],"taking":[229,287],"TAF":[237,280],"both":[244],"8%":[245,255],"lower,":[246,258],"whereas":[247],"5%":[257],"dissolution.":[263],"rapidly":[266],"had":[270],"unpleasant":[272],"taste.":[273],"Increases":[274],"decreases":[278],"concentrations":[283],"observed":[285],"EVG/COBI/FTC/TAF.":[289],"These":[290],"changes":[291],"judged":[293],"clinically":[296],"insignificant.":[297],"Dissolving":[298],"may":[302],"suitable":[304],"those":[306],"pill":[308],"challenges.":[310],"trial":[312],"registered":[314],"on":[315],"(":[316],"//clinicaltrials.gov":[317],"NCT03717129).":[318]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-11-01T00:00:00"}